| Literature DB >> 18282110 |
Ivan Osokine1, Ruby Hsu, Gabriel B Loeb, Michael T McManus.
Abstract
One of the most powerful techniques for studying the function of a gene is to disrupt the expression of that gene using genetic engineering strategies such as targeted recombination or viral integration of gene trap cassettes. The tremendous utility of these tools was recognized this year with the awarding of the Nobel Prize in Physiology or Medicine to Capecchi, Evans, and Smithies for their pioneering work in targeted recombination mutagenesis in mammals. Another noteworthy discovery made nearly a decade ago was the identification of a novel class of non-coding genes called microRNAs. MicroRNAs are among the largest known classes of regulatory elements with more than 1000 predicted to exist in the mouse genome. Over 50% of known microRNAs are located within introns of coding genes. Given that currently about half of the genes in mouse have been knocked out, we investigated the possibility that intronic microRNAs may have been coincidentally deleted or disrupted in some of these mouse models. We searched published murine knockout studies and gene trap embryonic stem cell line databases for cases where a microRNA was located within or near the manipulated genomic loci, finding almost 200 cases where microRNA expression may have been disrupted along with another gene. Our results draw attention to the need for careful planning in future knockout studies to minimize the unintentional disruption of microRNAs. These data also raise the possibility that many knockout studies may need to be reexamined to determine if loss of a microRNA contributes to the phenotypic consequences attributed to loss of a protein-encoding gene.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18282110 PMCID: PMC2242815 DOI: 10.1371/journal.pgen.0040034
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Figure 1Configurations of Protein:miRNA Gene Disruptions.
Retroviral gene traps have the potential to (A) ablate miRNA transcription or (B) lead to constitutive overexpression of the miRNA.
(C) Schematic of a recombinant gene-targeting strategy whereby an intronic miRNA is ablated or (D) the miRNA is upstream and/or downstream of the targeting cassette. Promoter, green; exon, blue; selection marker, white; splice acceptor or donor, yellow; transcriptional terminator, red.